Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

699
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
699
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

196
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
196
Lipid Absorption01:24

Lipid Absorption

526
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
526
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

586
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
586

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinician's Guide to the 2024 VA/DoD Clinical Practice Guideline for the Rehabilitation of Individuals With Lower Limb Amputation.

American journal of physical medicine & rehabilitation·2026
Same author

A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Asthma.

Annals of internal medicine·2026
Same author

Principles Supporting CKD Management in Primary Care: 2025 Veterans Affairs/Department of Defense Clinical Practice Guidelines.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Primary Care Management of Chronic Kidney Disease.

Annals of internal medicine·2025
Same author

Community of Practice Implementation: Leveraging Veterans Affairs/Department of Defense Diabetes Clinical Practice Guidelines and Data Insights.

Journal for healthcare quality : official publication of the National Association for Healthcare Quality·2025
Same author

Pharmacological and Somatic Treatments for First-Episode Psychosis and Schizophrenia: Synopsis of the US Department of Veterans Affairs and US Department of Defense Clinical Practice Guidelines.

Schizophrenia bulletin·2025

Related Experiment Video

Updated: Jul 20, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

Dyslipidemia Update.

Jennifer Ballard-Hernandez1, James Sall2

  • 1Cardiology Division, Department of Medicine; Department of Veterans Affairs, VA Long Beach Healthcare System, 5901 East 7th Street, Long Beach, CA 90822, USA.

The Nursing Clinics of North America
|August 3, 2023
PubMed
Summary

Cardiovascular disease (CVD) is a leading cause of death. This review covers current strategies for assessing, diagnosing, and treating dyslipidemia, a key factor in atherosclerotic CVD management.

Keywords:
Cardiovascular risk reductionDyslipidemiaHyperlipidemia

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.4K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Related Experiment Videos

Last Updated: Jul 20, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.4K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of death and illness in the U.S.
  • Atherosclerotic CVD development is influenced by modifiable and nonmodifiable risk factors.
  • Managing dyslipidemia is a cornerstone of current CVD therapeutic strategies.

Purpose of the Study:

  • To review current risk assessment, diagnosis, and treatment strategies for dyslipidemia.
  • To highlight the evolving landscape of lipid-lowering therapies.
  • To emphasize the importance of understanding these therapies for healthcare providers.

Main Methods:

  • Literature review of current guidelines and therapeutic options for dyslipidemia.
  • Analysis of risk factors contributing to atherosclerotic cardiovascular disease.
  • Synthesis of information on lipid-lowering medications and treatment approaches.

Main Results:

  • Dyslipidemia management is a dynamic field with expanding therapeutic targets.
  • Effective risk factor modification, particularly for dyslipidemia, is crucial for preventing CVD.
  • A comprehensive understanding of available lipid-lowering therapies is essential.

Conclusions:

  • Current strategies for dyslipidemia management are multifaceted, involving risk assessment, diagnosis, and evolving treatment options.
  • Healthcare providers must stay informed about the latest advancements in lipid-lowering therapies to effectively manage patients at risk for cardiovascular disease.
  • Continued focus on dyslipidemia treatment is vital for reducing CVD morbidity and mortality.